We'll all be fine. Matt's not diluting the company
Post# of 16816
We'll all be fine. Matt's not diluting the company, so the only "benefit" to BCAP being publicly traded is for shareholders to exchange shares between one another.
Honestly, for all I care Matt could delist BCAP, keep all existing shareholders, avoid all the BS hassle and still effect his business plan.
No-one deserves the criticism he's received. The delay in the Quarterly report is on the advise of his lawyer. There's nothing more Matt can do to release the Q until he receives the legal thumbs up.